Class II โ€” Potential Health Hazard

Potential health hazard โ€” use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Losartan Potassium Tablets Recalled by Strides Pharma Inc. Due to CGMP Deviations- AZIDO Impurity levels observed to be...

Date: May 18, 2022
Company: Strides Pharma Inc.
Status: Terminated
Source: FDA (Drug)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Strides Pharma Inc. directly.

Affected Products

Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816. 90 film coated tablets NDC 64380-934-05 1000 film coated tablets NDC 64380-934-08

Quantity: 381456 bottles

Why Was This Recalled?

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Strides Pharma Inc.

Strides Pharma Inc. has 8 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report